• About us
• Contact

Advertisement

Person › Details

Tom Clement (Qiagen N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA))

Clement, Tom (Qiagen 200901– VP Regulatory and Clinical Affairs before Roche + bioMérieux + Amersham)

 

	Organisation	Qiagen N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA)
	Group	Qiagen (Group)

Record changed: 2017-04-09

Advertisement

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.